|
Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study |
|
|
|
Titel: |
Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study |
Auteur: |
Lortholary, Olivier Chandesris, Marie Olivia Livideanu, Cristina Bulai Paul, Carle Guillet, Gérard Jassem, Ewa Niedoszytko, Marek Barete, Stéphane Verstovsek, Srdan Grattan, Clive Damaj, Gandhi Canioni, Danielle Fraitag, Sylvie Lhermitte, Ludovic Lavialle, Sophie Georgin Frenzel, Laurent Afrin, Lawrence B Hanssens, Katia Agopian, Julie Gaillard, Raphael Kinet, Jean-Pierre Auclair, Christian Mansfield, Colin Moussy, Alain Dubreuil, Patrice Hermine, Olivier |
Verschenen in: |
Lancet |
Paginering: |
Jaargang 389 (2017) nr. 10069 pagina's 9 p. |
Jaar: |
2017 |
Inhoud: |
|
Uitgever: |
Elsevier Ltd |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|